Provectus Biopharmaceuticals (PVCT) Return on Capital Employed [ROCE] (2011 - 2019)
Provectus Biopharmaceuticals' Return on Capital Employed [ROCE] came in at -1290.65% for Q2 2019.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Return on Capital Employed [ROCE] (2011 - 2019) Analysis & Trends
For FY2017, Provectus Biopharmaceuticals' Return on Capital Employed [ROCE] was -1438.35%, down 1213.13 percentage points from FY2016.
- Return on Capital Employed [ROCE] has declined in each of the last three years, with a five-year change of -1283.61 percentage points (FY2012 to FY2017).
- Going back by year, Return on Capital Employed [ROCE] was -225.22% in FY2016 (-96.74 pp), -128.48% in FY2015 (-71.70 pp), -56.78% in FY2014 (+46.67 pp) and -103.45% in FY2013 (+51.29 pp).
- The Q2 2019 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q4 2016.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2014 (a gain of 45.60 percentage points), and the weakest in Q4 2017 (a drop of 28339.55 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.86% |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -1,290.65% |
| Dec 31, 2017 | -28,747.65% |
| Sep 30, 2017 | -4,816.04% |
| Jun 30, 2017 | -1,658.09% |
| Dec 31, 2016 | -408.10% |
| Sep 30, 2016 | -538.74% |
| Jun 30, 2016 | -247.07% |
| Mar 31, 2016 | -174.08% |
| Dec 31, 2015 | -127.09% |
| Sep 30, 2015 | -56.83% |
| Jun 30, 2015 | -51.13% |
| Mar 31, 2015 | -54.88% |
| Dec 31, 2014 | -54.76% |
| Sep 30, 2014 | -72.46% |
| Jun 30, 2014 | -72.89% |
| Mar 31, 2014 | -72.39% |
| Dec 31, 2013 | -82.03% |
| Sep 30, 2013 | -118.06% |
| Dec 31, 2012 | -235.18% |
| Mar 31, 2012 | -195.54% |
API Access
Provectus Biopharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();